Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.48NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.112ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.112ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.112ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.112NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.274ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.274ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.274ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.274NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.515ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.515ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.515ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.515NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.370ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.370ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.370ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.370NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.118ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.118ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.118ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.118NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.137ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.137ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.137ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.137NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.309ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.309ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.309ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.309NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.632ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.632ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.632ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.632NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.72ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-17437.2China
B.1.1.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.72NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.108ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.108ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.108ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.108NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.332ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.332ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.332ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.332NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.42.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used